ERBB2 and neoplasm: In particular, 3 of the 5 mice that had been challenged with 2 × 105 4T1.2/HER2 cells per mouse showed complete tumor regression, while 1 of the 5 mice that had been challenged with 2 × 106 4T1.2/HER2 cells per mouse showed complete tumor regression.